These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2834487)

  • 1. [CY 222, a very low molecular weight heparin, in the curative treatment of deep venous thrombosis. Apropos of 95 cases. Clinical and phlebographic results].
    Janvier G; Dugrais G; Winnock S; Vergnes C; Boisseau M; Broussin J; Serise JM; Boissieras P; Videau J; Toulemonde F
    J Mal Vasc; 1987; 12 Suppl B():141-4. PubMed ID: 2834487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new treatment of deep venous thrombosis: low molecular weight heparin fractions. Randomized study].
    Faivre R; Neuhart Y; Kieffer Y; Apfel F; Magnin D; Didier D; Toulemonde F; Bassand JP; Maurat JP
    Presse Med; 1988 Feb; 17(5):197-200. PubMed ID: 2965375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial.
    Lopaciuk S; Meissner AJ; Filipecki S; Zawilska K; Sowier J; Ciesielski L; Bielawiec M; Glowinski S; Czestochowska E
    Thromb Haemost; 1992 Jul; 68(1):14-8. PubMed ID: 1325076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of deep venous thrombosis with a very low molecular weight heparin fragment (CY 222).
    Janvier G; Winnock S; Dugrais G; Vallet A; Dardel E; Serisé JM; Calen S; Vergnes C; Toulemonde F
    Haemostasis; 1987; 17(1-2):49-58. PubMed ID: 3596357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experiences in the administration of a low molecular weight heparin (Fragmin, Kabi-Vitrum) to healthy volunteers and in the treatment of established deep venous thrombosis.
    Bratt GA; Törnebohm E; Johanson M; Aberg W; Granqvist S; Lockner D
    Acta Chir Scand Suppl; 1988; 543():96-100. PubMed ID: 2847465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis. A collaborative European multicentre study.
    Thromb Haemost; 1991 Mar; 65(3):251-6. PubMed ID: 1646490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of a very low molecular weight heparin fragment (CY 222) compared to standard heparin in patients with deep venous thrombosis. A randomized study].
    Faivre R; Neuhart E; Kieffer Y; Bassand JP; Maurat JP
    J Mal Vasc; 1987; 12 Suppl B():145-6. PubMed ID: 2834488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis.
    Breddin HK; Kadziola Z; Scully M; Nakov R; Misselwitz F; Kakkar VV
    Thromb Haemost; 2003 Feb; 89(2):272-7. PubMed ID: 12574806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis.
    Lensing AW; Prins MH; Davidson BL; Hirsh J
    Arch Intern Med; 1995 Mar; 155(6):601-7. PubMed ID: 7887755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of deep venous thrombosis. Comparative study of a low molecular weight heparin fragment (Fragmin) by the subcutaneous route and standard heparin by the continuous intravenous route. A multicenter study].
    Aiach M; Fiessinger JN; Vitoux JF; Derlon A; Grollier G; Le Querrec A; Gouault-Heilmann M; Huet Y; Franco A; Polack B; Pouzol P; Dubois A; Schved JF; Boneu B; Guittard J; Sie P; Heilmann JJ; Kher A; Haye I
    Rev Med Interne; 1989; 10(4):375-81. PubMed ID: 2552552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open trial of enoxaparin in the treatment of deep vein thrombosis of the leg.
    Janvier G; Freyburger G; Winnock S; Dugrais G; Boisseau M; Boissiéras P
    Haemostasis; 1991; 21(3):161-8. PubMed ID: 1663476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The home treatment of deep vein thrombosis with low molecular weight heparin, forced mobilisation and compression.
    Labas P; Ohrádka B; Vladimír J; Cambal M
    Int Angiol; 2000 Dec; 19(4):303-7. PubMed ID: 11305727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of deep venous thrombosis with low molecular weight heparin (Fragmin)].
    Nesvold A; Ly B; Abildgaard U; Stiris M
    Tidsskr Nor Laegeforen; 1991 Nov; 111(27):3296-7. PubMed ID: 1659751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.
    Harenberg J; Stehle G; Blauth M; Huck K; Mall K; Heene DL
    Semin Thromb Hemost; 1997; 23(1):83-90. PubMed ID: 9156415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison between low molecular weight heparin (KABI 2165) and standard heparin in the intravenous treatment of deep venous thrombosis.
    Bratt G; Törnebohm E; Granqvist S; Aberg W; Lockner D
    Thromb Haemost; 1985 Dec; 54(4):813-7. PubMed ID: 3911482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An open study on the efficacy and tolerance of a low molecular weight heparin (CY 216) in the therapeutic treatment of deep venous thrombi in orthopedics].
    Wattrisse G; Lecoutre D; Groux-Pante C; Dufossez F
    Cah Anesthesiol; 1992; 40(1):37-42. PubMed ID: 1317243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of venous thrombosis with low molecular weight heparin. Progress and outlook].
    Fiessinger JN
    Bull Acad Natl Med; 1997 May; 181(5):875-83; discussion 883-5. PubMed ID: 9312362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The future of low molecular weight heparins in the curative treatment of deep venous thrombosis].
    St-Louis J; St-Louis JM
    Union Med Can; 1994 Mar; 123(3):147-51. PubMed ID: 8184510
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy and tolerance of low molecular weight heparin in the prevention of deep venous thrombosis during non-emergent total hip arthroplasty. A prospective, multicenter trial].
    Simon P; Kindermans A; Kempf JF; Postel M
    J Chir (Paris); 1990 May; 127(5):252-7. PubMed ID: 2165076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolytic and thrombolytic parameters in patients with deep vein thrombosis treated by low molecular weight and standard heparin.
    Faivre R; Neuhart E; Mirshahi M; Mirshahi M; Soria C; Soria J; Bassand JP; Caen JP; Maurat JP
    Semin Thromb Hemost; 1989 Oct; 15(4):435-9. PubMed ID: 2554504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.